Microbial Fermentation Technology Market (Product: Medical, Industrial, Alcoholic Beverages, and Food and Feed Products) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031
미생물 발효 기술 시장 - 보고서 범위
세계의 미생물 발효 기술 시장에 관한 TMR의 보고서는 과거와 현재의 성장 동향 및 2023년부터 2031년까지의 예측기간 동안 시장 지표의 귀중한 인사이트를 얻을 수 있는 기회를 연구하고 있습니다. 이 보고서는 세계의 미생물 발효 기술 시장 매출을 제공하고, 2023년을 기준 연도, 2031년을 예측 연도로 간주하여 2017년부터 2031년까지의 시장을 분석합니다. 이 보고서는 2023년부터 2031년까지의 세계 미생물 발효 기술 시장 연평균 성장률(CAGR %)도 제공합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서는 조사 활동의 대부분이 이루어지고, 애널리스트가 주요 오피니언 리더, 업계 리더, 오피니언 메이커와의 인터뷰를 실시했습니다. 2차 조사에는 미생물 발효 기술 시장을 이해하기 위해 주요 기업의 제품 문헌, 연차 보고서, 프레스 릴리스 및 관련 문서에 대한 참조가 포함됩니다.
| 시장 현황 |
| 2023년 시장 가치 |
309억 달러 |
| 2031년 시장 가치 |
496억 달러 |
| CAGR |
5.5% |
이 보고서는 세계의 미생물 발효 기술 시장 경쟁 상황을 자세히 조사했습니다. 세계의 미생물 발효 기술 시장에서 활동하는 주요 기업이 확인되었으며, 이들 각각이 다양한 속성의 관점에서 프로파일링됩니다. 기업 개요, 재무 상황, 최근의 동향, SWOT는 이 보고서에서 소개되고 있는 세계의 미생물 발효 기술 시장 기업의 속성입니다.
목차
제1장 주요 요약
제2장 가정과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
- 시장 세분화
- 개요
- 시장 역학
- 세계 시장 분석과 예측, 2022-2031년
제5장 중요한 인사이트
- 파이프라인 분석
- COVID-19 팬데믹이 업계에 미치는 영향
제6장 시장 분석과 예측 : 제품별
- 서론과 정의
- 주요 조사 결과/발전
- 시장 금액 예측 : 제품별, 2017-2031
- 의료
- 항생제
- 프로바이오틱스
- 단클론항체
- 재조합 단백질
- 기타
- 산업
- 주류
- 식품·사료 제품
- 시장 매력 : 제품별
제7장 세계 시장 분석과 예측 : 최종 이용 업계별
- 서론과 정의
- 주요 조사 결과/발전
- 시장 금액 예측 : 최종 이용 업계별, 2017-2031
- 바이오의약품
- 식품·사료
- CRO·CMO
- 학술연구기관
- 기타
- 시장 매력 : 최종 이용 업계별
제8장 세계 시장 분석과 예측 : 지역별
- 주요 조사 결과
- 시장 금액 예측 : 지역별, 2017-2031
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- 시장 매력 : 지역별
제9장 북미 시장 분석과 예측
제10장 유럽 시장 분석과 예측
제11장 아시아태평양 시장 분석과 예측
제12장 라틴아메리카 시장 분석과 예측
제13장 중동 및 아프리카 시장 분석과 예측
제14장 경쟁 상황
- 시장 기업 - 경쟁 매트릭스(기업 계층 및 규모별)
- 시장 점유율 분석 : 기업별(2022년)
- 기업 개요
- Biocon
- Danone Limited
- Lonza
- United Breweries Ltd.
- Amyris
- Novozymes
- TerraVia Holdings, Inc.
- BioVectra
- DSM
- F. Hoffmann La-Roche Ltd.
KSM
Microbial Fermentation Technology Market - Scope of Report
TMR's report on the global microbial fermentation technology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global microbial fermentation technology market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global microbial fermentation technology market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the microbial fermentation technology market.
| Market Snapshot |
|---|
| Market Value in 2023 | US$ 30.9 Bn |
| Market Value in 2031 | US$ 49.6 Bn |
| CAGR | 5.5% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global microbial fermentation technology market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global microbial fermentation technology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global microbial fermentation technology market.
The report delves into the competitive landscape of the global microbial fermentation technology market. Key players operating in the global microbial fermentation technology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global microbial fermentation technology market profiled in this report.
Key Questions Answered in Global microbial fermentation technology Market Report:
- What is the sales/revenue generated by microbial fermentation technology across all regions during the forecast period?
- What are the opportunities in the global microbial fermentation technology market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Microbial Fermentation Technology Market - Research Objectives and Research Approach
The comprehensive report on the global microbial fermentation technology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global microbial fermentation technology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global microbial fermentation technology market.
Table of Contents
1. Executive Summary
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Microbial Fermentation Technology Market
4. Market Overview
- 4.1. Market Segmentation
- 4.1.1. Segment Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Microbial Fermentation Technology Market Analysis and Forecast, 2022-2031
5. Key Insights
- 5.1. Pipeline Analysis
- 5.2. COVID-19 Pandemic Impact on Industry
6. Microbial Fermentation Technology Market Analysis and Forecast, by Product
- 6.1. Introduction and Definitions
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Medical
- 6.3.1.1. Antibiotics
- 6.3.1.2. Probiotics
- 6.3.1.3. Monoclonal Antibodies
- 6.3.1.4. Recombinant Proteins
- 6.3.1.5. Other Biosimilars
- 6.3.2. Industrial
- 6.3.2.1. Acetone, Ethanol & Butanol
- 6.3.2.2. Enzymes & Amino Acids
- 6.3.3. Alcoholic Beverages
- 6.3.3.1. Beer
- 6.3.3.2. Spirits
- 6.3.3.3. Wine
- 6.3.3.4. Others
- 6.3.4. Food & Feed Products
- 6.4. Market Attractiveness, by Product
7. Global Microbial Fermentation Technology Market Analysis and Forecast, by End-user Industry
- 7.1. Introduction and Definitions
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by End-user Industry, 2017-2031
- 7.3.1. Biopharmaceutical
- 7.3.2. Food & Feed
- 7.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
- 7.3.4. Academic Research Institutes
- 7.3.5. Others
- 7.4. Market Attractiveness, by End-user Industry
8. Global Microbial Fermentation Technology Market Analysis and Forecast, by Region
- 8.1. Key Findings
- 8.2. Market Value Forecast, by Region, 2017-2031
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3. Market Attractiveness, by Region
9. North America Microbial Fermentation Technology Market Analysis and Forecast
- 9.1. Introduction
- 9.2. Market Value Forecast, by Product, 2022-2031
- 9.2.1. Medical
- 9.2.1.1. Antibiotics
- 9.2.1.2. Probiotics
- 9.2.1.3. Monoclonal Antibodies
- 9.2.1.4. Recombinant Proteins
- 9.2.1.5. Other Biosimilars
- 9.2.2. Industrial
- 9.2.2.1. Acetone, Ethanol & Butanol
- 9.2.2.2. Enzymes & Amino Acids
- 9.2.3. Alcoholic Beverages
- 9.2.3.1. Beer
- 9.2.3.2. Spirits
- 9.2.3.3. Wine
- 9.2.3.4. Others
- 9.2.4. Food & Feed Products
- 9.3. Market Value Forecast, by End-user Industry, 2022-2031
- 9.3.1. Biopharmaceutical
- 9.3.2. Food & Feed
- 9.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
- 9.3.4. Academic Research Institutes
- 9.3.5. Others
- 9.4. Market Value Forecast, by Country, 2022-2031
- 9.4.1. U.S.
- 9.4.2. Canada
- 9.5. Market Attractiveness Analysis
- 9.5.1. By Product
- 9.5.2. By End-user Industry
- 9.5.3. By Country
10. Europe Microbial Fermentation Technology Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Product, 2022-2031
- 10.2.1. Medical
- 10.2.1.1. Antibiotics
- 10.2.1.2. Probiotics
- 10.2.1.3. Monoclonal Antibodies
- 10.2.1.4. Recombinant Proteins
- 10.2.1.5. Other Biosimilars
- 10.2.2. Industrial
- 10.2.2.1. Acetone, Ethanol & Butanol
- 10.2.2.2. Enzymes & Amino Acids
- 10.2.3. Alcoholic Beverages
- 10.2.3.1. Beer
- 10.2.3.2. Spirits
- 10.2.3.3. Wine
- 10.2.3.4. Others
- 10.2.4. Food & Feed Products
- 10.3. Market Value Forecast, by End-user Industry, 2022-2031
- 10.3.1. Biopharmaceutical
- 10.3.2. Food & Feed
- 10.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
- 10.3.4. Academic Research Institutes
- 10.3.5. Others
- 10.4. Market Value Forecast, by Country/Sub-region, 2022-2031
- 10.4.1. Germany
- 10.4.2. U.K.
- 10.4.3. France
- 10.4.4. Italy
- 10.4.5. Spain
- 10.4.6. Rest of Europe
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Product
- 10.5.2. By End-user Industry
- 10.5.3. By Country/Sub-region
11. Asia Pacific Microbial Fermentation Technology Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product, 2022-2031
- 11.2.1. Medical
- 11.2.1.1. Antibiotics
- 11.2.1.2. Probiotics
- 11.2.1.3. Monoclonal Antibodies
- 11.2.1.4. Recombinant Proteins
- 11.2.1.5. Other Biosimilars
- 11.2.2. Industrial
- 11.2.2.1. Acetone, Ethanol & Butanol
- 11.2.2.2. Enzymes & Amino Acids
- 11.2.3. Alcoholic Beverages
- 11.2.3.1. Beer
- 11.2.3.2. Spirits
- 11.2.3.3. Wine
- 11.2.3.4. Others
- 11.2.4. Food & Feed Products
- 11.3. Market Value Forecast, by End-user Industry, 2022-2031
- 11.3.1. Biopharmaceutical
- 11.3.2. Food & Feed
- 11.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
- 11.3.4. Academic Research Institutes
- 11.3.5. Others
- 11.4. Market Value Forecast, by Country/Sub-region, 2022-2031
- 11.4.1. China
- 11.4.2. Japan
- 11.4.3. India
- 11.4.4. Australia & New Zealand
- 11.4.5. Rest of Asia Pacific
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Product
- 11.5.2. By End-user Industry
- 11.5.3. By Country/Sub-region
12. Latin America Microbial Fermentation Technology Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product, 2022-2031
- 12.2.1. Medical
- 12.2.1.1. Antibiotics
- 12.2.1.2. Probiotics
- 12.2.1.3. Monoclonal Antibodies
- 12.2.1.4. Recombinant Proteins
- 12.2.1.5. Other Biosimilars
- 12.2.2. Industrial
- 12.2.2.1. Acetone, Ethanol & Butanol
- 12.2.2.2. Enzymes & Amino Acids
- 12.2.3. Alcoholic Beverages
- 12.2.3.1. Beer
- 12.2.3.2. Spirits
- 12.2.3.3. Wine
- 12.2.3.4. Others
- 12.2.4. Food & Feed Products
- 12.3. Market Value Forecast, by End-user Industry, 2022-2031
- 12.3.1. Biopharmaceutical
- 12.3.2. Food & Feed
- 12.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
- 12.3.4. Academic Research Institutes
- 12.3.5. Others
- 12.4. Market Value Forecast, by Country/Sub-region, 2022-2031
- 12.4.1. Brazil
- 12.4.2. Mexico
- 12.4.3. Rest of Latin America
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Product
- 12.5.2. By End-user Industry
- 12.5.3. By Country/Sub-region
13. Middle East & Africa Microbial Fermentation Technology Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product, 2022-2031
- 13.2.1. Medical
- 13.2.1.1. Antibiotics
- 13.2.1.2. Probiotics
- 13.2.1.3. Monoclonal Antibodies
- 13.2.1.4. Recombinant Proteins
- 13.2.1.5. Other Biosimilars
- 13.2.2. Industrial
- 13.2.2.1. Acetone, Ethanol & Butanol
- 13.2.2.2. Enzymes & Amino Acids
- 13.2.3. Alcoholic Beverages
- 13.2.3.1. Beer
- 13.2.3.2. Spirits
- 13.2.3.3. Wine
- 13.2.3.4. Others
- 13.2.4. Food & Feed Products
- 13.3. Market Value Forecast, by End-user Industry, 2022-2031
- 13.3.1. Biopharmaceutical
- 13.3.2. Food & Feed
- 13.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
- 13.3.4. Academic Research Institutes
- 13.3.5. Others
- 13.4. Market Value Forecast, by Country/Sub-region, 2022-2031
- 13.4.1. GCC Countries
- 13.4.2. South Africa
- 13.4.3. Rest of Middle East & Africa
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Product
- 13.5.2. By End-user Industry
- 13.5.3. By Country/Sub-region
14. Competition Landscape
- 14.1. Market Player - Competition Matrix (By Tier and Size of Companies)
- 14.2. Market Share Analysis, by Company (2022)
- 14.3. Company Profiles
- 14.3.1. Biocon
- 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.1.2. Product Portfolio
- 14.3.1.3. Financial Overview
- 14.3.1.4. SWOT Analysis
- 14.3.1.5. Strategic Overview
- 14.3.2. Danone Limited
- 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.2.2. Product Portfolio
- 14.3.2.3. Financial Overview
- 14.3.2.4. SWOT Analysis
- 14.3.2.5. Strategic Overview
- 14.3.3. Lonza
- 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.3.2. Product Portfolio
- 14.3.3.3. Financial Overview
- 14.3.3.4. SWOT Analysis
- 14.3.3.5. Strategic Overview
- 14.3.4. United Breweries Ltd.
- 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.4.2. Product Portfolio
- 14.3.4.3. Financial Overview
- 14.3.4.4. SWOT Analysis
- 14.3.4.5. Strategic Overview
- 14.3.5. Amyris
- 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.5.2. Product Portfolio
- 14.3.5.3. Financial Overview
- 14.3.5.4. SWOT Analysis
- 14.3.5.5. Strategic Overview
- 14.3.6. Novozymes
- 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.6.2. Product Portfolio
- 14.3.6.3. Financial Overview
- 14.3.6.4. SWOT Analysis
- 14.3.6.5. Strategic Overview
- 14.3.7. TerraVia Holdings, Inc.
- 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.7.2. Product Portfolio
- 14.3.7.3. Financial Overview
- 14.3.7.4. SWOT Analysis
- 14.3.7.5. Strategic Overview
- 14.3.8. BioVectra
- 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.8.2. Product Portfolio
- 14.3.8.3. Financial Overview
- 14.3.8.4. SWOT Analysis
- 14.3.8.5. Strategic Overview
- 14.3.9. DSM
- 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.9.2. Product Portfolio
- 14.3.9.3. Financial Overview
- 14.3.9.4. SWOT Analysis
- 14.3.9.5. Strategic Overview
- 14.3.10. F. Hoffmann La-Roche Ltd.
- 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.10.2. Product Portfolio
- 14.3.10.3. Financial Overview
- 14.3.10.4. SWOT Analysis
- 14.3.10.5. Strategic Overview
